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Editor’s Introduction 
Globalizing Health Politics in the 
New Century1
Ted Schrecker
Introduction
Health is now firmly established on the global political agenda. With varying 
degrees of prominence, health issues ave been discussed at every summit of the 
G7/G8 since 2001. As noted in Chapter 11, the value of development assistance for 
health roughly quadrupled between 1990 and 2007 – a quantitative phenomenon 
that was accompanied qualitatively by the emergence of important new sources of 
aid (notably the Bill & Melinda Gates Foundation) and channels for disbursing aid 
(most notably the Global Fund to Fight HIV/AIDS, Tuberculosis and Malaria). The 
years 2010 and 2011 saw no fewer than four major diplomatic meetings on health or 
health-related issues: the High-Level Plenary Meeting of the UN General Assembly 
on the Millennium Development Goals (subsequently MDG Summit) in September 
2010; the UN High-Level Meeting on AIDS in June 2011; the UN High-Level Meeting 
on Non-communic ble Diseases (NCDs; subsequently NCD Summit) in September 
of that year; and the World Conference on Social Determinants of Health in Brazil 
(subsequently WCSDH) the following month. Although it is important not to 
confuse flurries of meetings with genuine progress toward improving the health of 
populations, it is also important not to neglect the significance of such events or the 
political commitment (even at the level of rhetoric) that they reflect.
1  I would like to express sincere thanks to Kathleen McGovern, the incredibly well-
organized research assistant who made possible the completion of this manuscript during a 
tumultuous time in my professional life; to Ashgate Publishing for their patience in awaiting 
this volume; and most especially to all contributors for raising the bar with respect to the 
social scientific study of global health.
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2
The Millennium Development Goals (MDGs) arose from a UN General 
Assembly resolution passed in the year 2000. Three of the eight MDGs are 
specifically concerned with health (child health, maternal health and AIDS and 
other major communicable diseases); progress toward every one of the seven 
substantive goals, which relate to poverty and hunger, universal education, gender 
equality and environmental sustainability, has the potential for important positive 
impacts on population health. (The eighth goal, developing a global partnership 
for development, is arguably the most important in terms of long-term reductions 
in health disparities, yet less amenable to assessments of progress with respect to 
specific outcomes.) The MDG Summit saw announced commitments of more than 
USD40 billion in support of a strategy for women’s and children’s health, widely 
seen as a neglected dimension of the MDGs, although it is not clear how much 
of that amount genuinely represents ‘new money’ rather than a repackaging of 
existing commitments. This is a recurring problem in the quest for good press on 
development issues, yet from a long-term perspective the fact that governments feel 
the need to generate attention to the resources they are committing to development 
is itself significant.
Rightly or wrongly, the MDGs have become a focus for global health and 
development policy, perhaps because the targets that were developed under the 
auspices of the UN Secretary General (United Nations 2001) with respect to at 
least the first seven goals are in theory amenable to quantitative measurement of 
progress, although it has been argued that necessary precision is unattainable in 
practice (Attaran 2005). More fundamentally, the modest nature of many of the 
goals and targets (halving the proportion of people worldwide afflicted by extreme 
poverty and hunger; improving the living conditions of at least 100 million slum 
dwellers, when the overall number was projected to increase to 1.4 billion in 2020), 
against the background of a quadrupling in the value of the world’s economic 
product between 1981 and 2005, led some to characterize them as the ‘Minimal 
Development Goals’. Nevertheless, their very existence was and is significant, 
and provided the opportunity for concentrating governmental, academic and 
civil society attention.2 The MDGs also mean that the international community, 
again apart from issues of definition, cannot avoid visible engagement with the 
question of what to do post-2015. Many chapters in this volume contribute to our 
understanding of how that engagement may unfold.
AIDS became n international issue relatively early in the short history of the 
epidemic, as reflected by the establishment in 1996 of the Joint United Nations 
Programme on HIV/AIDS (UNAIDS).3 As noted in Chapter 8, this happened at 
2 As for instance in the case of the Countdown to 2015 initiative (http://www.
countdown2015mnch.org/) that has tracked progress on maternal, newborn and child health. 
This is a partnership of 23 universities or university faculties, civil society organizations 
(CSOs), UN agencies, bilateral aid agencies, professional organizations, the World Bank, The 
Lancet, the ubiquitous Bill & Melinda Gates Foundation and NORAD.
3  For a remarkably unvarnished official history of that organization’s first ten years, 
see Knight (2008).
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Editor’s Introduction
3
a time when, in the United States in particular, the spread of HIV infection was 
coming to be viewed by much of the foreign policy establishment as a threat to 
security. One of the most prominent good-news stories in global health is the more 
than tenfold increase between 1998 and the end of 2009 in the number of people 
living with HIV infection who are receiving antiretroviral therapy (World Health 
Organization, UNAIDS and UNICEF 2010). The complex political background to 
that accomplishment includes trans-nationally coordinated civil society activism 
and direct confrontations with the power of the pharmaceutical industry. The 
2011 High-Level Meeting on AIDS adopted a Political Declaration (United Nations 
General Assembly 2011) – not in any way a binding commitment4 – that cited the 
HIV epidemic as a ‘global emergency’ and an ‘unprecedented human catastrophe 
inflicting immense suffering on countries, communities and families throughout 
the world’ (¶ 7–8), and voiced ‘deep concern that funding devoted to HIV and AIDS 
responses is still not commensurate with the magnitude of the epidemic’ (¶ 14). 
The appropriateness of this concern is underscored by the view, within the United 
States at least, that the ‘ballooning entitlement burden’ of AIDS treatment spending 
in low- and middle-income countries (LMICs) represents a ‘state supported 
international welfare program’ that is ‘hard to justify on investment grounds’ (Over 
2008), and by the fact that total donor support from 15 governments, including that 
of the US, for AIDS treatment and prevention in 2010 dropped by 10 per cent from 
its 2009 level (Kates, Wexler, Lief, Avila and Gobet 2011).
The MDGs make no specific mention of NCDs, and the NCD Summit (convened 
by the General Assembly) was an overdue effort to increase the attention devoted 
to NCDs on the international stage (Beaglehole et al. 2011). Development assistance 
is an imperfect proxy for the importance attached to an issue by countries that 
occupy the commanding heights f the world system, although its significance in 
recipient countries, at least when health systems are involved, is hard to overstate. 
Although estimates of dollar amounts vary, it is clear that NCDs have received 
only a fraction of the donor funding directed to communicable diseases like AIDS, 
or even to maternal, newborn and child health (MNCH), although the contribution 
to the burden of illness in LMICs is comparable (Nugent and Feigl 2010; Institute 
for Health Metrics and Evaluation 2011) – and the prevalence of NCDs such as 
cardiovascular disease, cancer and diabetes is increasing rapidly in most such 
countries, leading to the phenomenon of a double burden of disease. Explanations 
include the persistent misconception that NCDs are diseases of affluence (Ezzati 
et al. 2005) and the lack of widespread political mobilization of the kind that 
influenced responses to AIDS and, more recently, to MNCH. In advance of the NCD 
Summit, networks of global health professionals expressed hope for agreement 
on supporting a limited number of priority interventions in the areas of tobacco 
control, dietary salt intake, diet and physical activity, alcohol control and multi-
4 Leaving aside the problematic nature of bindingness in international law – a problem 
that is especially acute with respect to human rights treaties (see Chapter 14).
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4
drug combinations for people at high risk of cardiovascular disease.5 Concern was 
also being expressed that trans-national corporate interests, including the food 
processing and alcohol industries as well as pharmaceutical firms concerned about 
proposals to expand access to essential medicines, were shaping the negotiating 
positions of high-income countries in the pre-conference drafting sessions where 
the real diplomatic action takes place (Stuckler, Basu and McKee 2011; Cohen 2011).
The WCSDH, organized by WHO, was the outcome of a sequence of events 
that began in 2005 with WHO’s establishment of a Commission on Social 
Determinants of Health (see Chapter 13). That initiative reflected an accumulation 
of research evidence that many of the most important influence  on health involve 
the conditions of life and work rather than just the operation of health systems, 
and are deeply rooted in the structure of social arrangements and the unequal 
distributions of power and resources that shape those arr ngements. Even within 
national borders, using this insight effectively as the basis for specific policies 
and interventions faces formidable barriers not only because of the implied (and 
sometimes explicit) threat to existing economic and political interests, but also 
because of administrative requirements for coordination among elements of 
government, many of which are not primarily concerned with health, and, in some 
cases, the difficulty of mobilizing effective political support. These problems are 
multiplied at the international level, where no organized constituencies for action 
on social determinants of health are comparable to (for example) the medically 
oriented, disease-focused organizations6 comprising the NCD Alliance that was 
launched in 2009. In their absence, a tiny unit within the cash-strapped Geneva 
secretariat of WHO organized the conference while following up in other ways 
on the Commission’s recommendations and a subsequent World Health Assembly 
resolution of support. It is also interesting to note the disjuncture between the 
Commission’s holistic approach nd the behavioural, individualized interventions 
advocated in advance of the NCD meeting (Beaglehole et al. 2011) – a shopping 
list indistinguishable from the approaches to health education and promotion 
fashionable in many high-income countries circa 1980.
The preceding discussion can only hint at the institutional complexity of 
contemporary global health politics. If dissertations have not already been started 
about these events, their antecedents and significance, they soon will be. Further 
complexity is introduced by the effects on health on developments such as global 
environmental change (see Chapter 5) and the financial crises that are, for the 
moment, an inescapable corollary of global financial integration (Hopkins 2006; 
Schrecker forthcoming). The point is to demonstrate the close connection of health 
outcomes to international policy and politics, and also to suggest the theoretical 
challenges thereby presented for conventional frames of reference in the study of 
5 See in particular Beaglehole et al. (2011) – 44 authors writing in The Lancet, a journal 
whose role as a node in physician-dominated transnational elite networks would merit a 
chapter in itself if this volume were considerably larger.
6  World Heart Federation, International Diabetes Federation, Union for International 
Cancer Control, and International Union against Tuberculosis and Lung Disease.
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Editor’s Introduction
5
international relations. The threat of HIV infection to the national security of powerful 
actors in the international system, once invoked as a justification for concern, was 
almost certainly overblown; national economies and societies devastated by the 
epidemic have proved surprisingly resilient. States in sub-Saharan Africa and 
indeed elsewhere are failing or on the brink of failure for many reasons, but AIDS 
is not among them. Yet despite the fact that 19 out of every 20 new HIV infections 
occur in LMICs, the epidemic remains a focus of attention. The continued salience 
of global health is even more challenging to realist perspectives when other causes 
of illness or death are involved. David Fidler, a leading student of the global health 
diplomacy (GHD) exemplified by the four meetings just described, notes:
Although political and economic connections and interactions between 
the United States and India are increasing, neither n tional health nor 
economic prosperity in the United States depends on whether India 
controls obesity related diseases, and vice versa. Neither security nor 
the protection of human rights in the Europ an Union depends on 
whether countries in sub-Saharan Africa control diseases driven by 
tropical climatic conditions or local water or air pollution because 
these disease threats pose no real danger to populations in the 
European Union. (Fidler 2011, 36)
Familiar invocations of global interconnectedness have clear limits; conversely the 
presence and persistence of MNCH, NCDs and social determinants of health on 
international agendas indicates the extent to which health foreign policy (a term 
considerably more inclusive than GHD) has moved beyond considerations of 
national interest that are central to the realist perspective on international relations.
How should social scientists approach the study of these developments? 
In an article decrying the predisposition of international relations scholars 
toward ‘academic sectarianism’ in which competing research traditions seldom 
communicate meaningfully with one another, David Lake asked readers to:
[I]magine the contributions that we as scholars could make if we 
devoted our professional and intellectual energies to studying things 
that matter. Imagine reorganizing our research and professional 
associations around problems, not approaches. Imagine as well a 
graduate seminar not organized around research traditions but topics 
like Global Climate Change, Growth and Development, Economic and 
Political Inequality, and Genocide and Political Violence. The seminar 
discussion could then focus on ‘what do we know?’ rather than ‘what 
are the central tenets of this particular sect?’ (Lake 2011, 471)
The eclectic nature of the contributions to this book shows that many investigators 
concerned with the study of health on a global scale are already doing (or at least 
trying to do) what Lake recommends. The selection of contributions to this book 
also reflects the need for trans-disciplinarity in the study of large, complex problems 
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6
of the kind to which Lake refers. International relations, political economy (my 
own home discipline), and even the social sciences as a whole will not have all the 
relevant answers. This is particularly true of global health, where at least some 
knowledge of relevant life sciences is indispensable. No one can talk sensibly about 
AIDS policy and politics for very long without at least a basic understanding of 
the etiology of HIV infection and the mechanisms of transmission, although social 
scientists have occasionally tried. So have countless politicians, sounding even 
sillier. The initial reaction of some readers to several chapters may be: ‘This isn’t 
about international relations.’ No, it isn’t, at least in a sense that will be immediately 
familiar to readers of International Studies Quarterly. That’s the point. Their initial 
reaction may also be: ‘This isn’t about health, it’s about economics and politics.’ I 
and many, although perhaps not all, contributors to this volume view those as in 
practice inseparable.
History and Perspectives
Historian Monica Green based the book’s first chapter on a university course 
organized along lines of which Lake would almost certainly approve. Grounding 
her analysis in a thorough understandings of the specifics of communicable 
disease transmission, she argues first of all for a time frame that is radically longer 
than many of us are accustomed to, starting about 10,000 years ago (giving new 
meaning to the Braudelian idea of la longue durée) with ‘the beginnings of human 
agriculture and settled society’. She draws on advances in life sciences such as 
an ‘epidemiologically rich genomics’ that underscores the importance of animal-
human transmission. Green’s trenchant analysis of the interplay between biology 
and culture, and its implications for the response to specific communicable 
diseases, compares and contrasts responses to leprosy in the nineteenth century 
and HIV/AIDS in the late twentieth century. Green concludes with three 
injunctions for global health researchers, each of which also has implications for 
public health practice in the field: (1) think about more than one disease at a 
time; (2) historicize everything, a point revisited in different ways in Chapters 
2, 9 and 10; (3) take ‘global’ seriously, drawing on disciplines as disparate as 
anthropology and genomics. Green’s breadth of reading and demonstration of 
the practical relevance of history are only two of the reasons to envy her students, 
and to hope that her course is somehow syndicated or otherwise enabled to reach 
a much larger audience.
In the chapter that follows another historian, Anne-Emanuelle Birn, shortens 
the time frame somewhat and moves to a finer-grained level of analysis. She 
situates tropical medicine (still featured in the name of one of the world’s leading 
rese rch institutions, the London School of Hygiene and Tropical Medicine) with 
reference to a colonial project that exploited labour on a massive scale, but also 
required some protections for the health of colonists. Domestically, she links 
the industrial revolution and its immense human costs to the to ‘the emergence 
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7
of modern public health’ – a linkage that has also been emphasized by Simon 
Szreter (1999) in discussing the relevance of nineteenth century public health 
politics in England for contemporary LMICs. In the twentieth century these 
two patterns of thought and practice converged. The Rockefeller Foundation, 
financed by a fortune made in the industry central to that century’s economic 
history,7 played a crucial role in that process (at least in the western hemisphere) 
and shaped the agenda of international health policy and practice, especially in 
the years preceding World War II, but Birn shows that many other actors were 
already involved. Readers should consult her other published work (cited in the 
bibliography) for more extensive detail, and consider contemporary parallels to 
her conclusion that international health in earlier stages of its development was 
‘focused on disease control to facilitate conquest and occupation, increase worker 
productivity in factories, mines and plantations in metropolitan and colonial 
settings, fend off epidemic unrest, and ensure a smooth and uninterrupted trade 
system’.
In Chapter 3, political scientist Sara Glasgow examines the internal presumptions 
of public health discourse on NCDs, focusing on ‘the risk mentality’. Risk is a 
pervasive concept in contemporary social policy and the analysis thereof, with 
some authors claiming to identify the phenomenon of ‘risk society’ (Beck 1992). Few 
have reflected seriously on the politics behind recasting various social processes 
in terms of risk – for instance, on how the risk society concept was used in the 
United Kingdom as a basis for attacking the redistributive aims of the welfare state 
as old-fashioned and outmoded (Giddens 1998, chapter 4). Glasgow, a notable 
exception, argues persuasively that epidemiologists’ focus on risk factors defined 
in individualized terms has led public health research and practice to neglect 
structural influences on those behaviours. She proceeds to argue that many social 
scientists working on global he lth issues neglect ‘the latent political norms that 
suffuse the supposedly objective science of public health’, ignoring the fact that 
public health cannot be value-free. This is both an overdue critique of epidemiology 
and an admonition to social scientists studying the politics of health within and 
across national borders. The contrast between the highly individualized, risk factor-
oriented approach guiding the September, 2011 NCDs meeting – WHO’s web page 
(World Health Organization 2011; accessed September 3, 2011) reduced the issues 
to four diseases (cancer, cardiovascular diseases, chronic obstructive pulmonary 
disease and diabetes) and four risk factors (tobacco use, unhealthy diet, harmful 
use of alcohol and physical activity) – and the approach of the Commission on 
Social Determinants of Health underscores the value of Glasgow’s analysis.
Chapter 4 is the only one explicitly organized around the perspective of a single 
discipline. This was my idea, because anthropologists have been singularly effective 
in making the connections between macro-level social and economic processes and 
7  An obvious parallel can be drawn with the emergence of the Bill & Melinda Gates 
Foundation as a major actor in global public health; it can be argued that the products and 
activities of Standard Oil and Microsoft were of comparable significance in successive waves 
of industrialization.
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health outcomes and experiences at the individual, household and community 
level. Vinh-Kim Nguyen’s chapter combines an anthropologist’s scepticism about 
universals with a succinct thematic overview of critical definitions of, and approaches 
to, the unavoidably contested concept and phenomenon of globalization.8 
Appropriately, in my view at least, the overview is grounded in political economy 
and emphasizes globalization’s tendency to magnify inequalities. He further 
inquires into how relations between knowledge and power are reproduced in 
global health research and practice, in an important complement to Glasgow’s 
analysis that asks ‘how the body is located within historical and social relations’, 
and ends with a number of more specific applications of anthropological analysis 
to such phenomena as therapeutic power (‘the power to manage misfortune’, in 
the author’s memorable phrase) and commodification of the body. Understandings 
of how the latter process is inextricably linked with the underlying logics of 
globalization have been particularly enriched by the work of anthropologists on 
topics as diverse as the globalization of the clinical trials industry (Petryna 2009) 
and the emergence of a trans-border trade in human tissues and organs (Scheper-
Hughes 2004; 2005).
Issues and Challenges
Any comprehensive inventory of global health issues and challenges that are 
appropriate topics for social science inquiry would require far more space than 
is available here. For that reason, some relatively familiar issues like SARS, 
pandemic influenza and tobacco control are dealt with rather briefly, and in the 
context of larger questions and debates. The focus is on issues that either have 
received insufficient attention in the study of global health politics (like global 
environmental change, and the interface between neo-liberalism and the treatment 
of health as a security issue) or raise important theoretical or methodological issues 
(like globalization’s influence on social determinants of health at the metropolitan 
scale, or how the Foucauldian concept of biopolitics can inform understandings of 
the situation of poor countries and racialized populations in the world economy).
8  On some academic conventions, at this point in the introduction I should have 
embarked on a discussion of competing definitions of globalization. I have not done so 
because in my view the definition as ‘[a] pattern of transnational economic integration 
animated by the ideal of creating self-regulating global markets for goods, services, capital, 
technology, and skills’ (Eyoh and Sandbrook 2003) is a sufficient starting point; Chapter 
4 provides all necessary elaboration; and the process is in any event understood at a level 
hard for academics to comprehend by those who have lost their jobs as production relocated 
to Mexico or China or their homes through forcible eviction in the service of ‘higher value 
uses’ that enrich real estate capitalists. Both are among the increasingly commonplace 
manifestations of the process described by Eyoh and Sandbrook.
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9
The focus of the chapters in this section is also, in some cases, far removed 
from health outcomes and the conventional subject matter of research on health 
policy and politics. Authors’ concern is rather with the economics and politics of a 
changing world system, and the consequences of that system’s dynamics ‘on the 
ground’. In Chapter 4, Vinh-Kim Nguyen refers to Virchow’s vision of a social 
medicine explicitly concerned with such matters as poverty; I would add Bertolt 
Brecht’s memorable 1938 poem ‘A Worker’s Speech to a Doctor’, part of which 
reads:
The pain in our shoulder comes
You say, from the damp; and this is also the reason
For the stain on the wall of our flat.
So tell us:
Where does the damp come from?
The fundamental message of Virchow, Brecht and the Commission on Social 
Determinants of Health alike is that health cannot responsibly be understood or 
considered in isolation from politics and economics – in other words, without 
asking where the damp comes from and why workers have to live with it while 
doctors do not. In turn, health outcomes cannot be understood in isolation from 
global-scale processes like trade and capital mobility, or from the institutions that 
organize those processes and protect the underlying asymmetries of power and 
resources.
In Chapter 5, Charmian Bennett and Tony McMichael add a further layer of 
complexity to the already complicated map of influences on health in a global 
context. Green demonstrates the importance of understanding the biology of disease-
causing organisms; Bennett and McMichael demonstrate the incompleteness of 
any approach to global health that does not consider the indispensable life support 
functions provided by the natural environment. They note that ‘the form of the 
requisite research and policy responses can seem far removed from the tidy 
comfort of reductionist, item-specific research and policy formulation’, which 
ranks as a masterpiece of understatement. Consider the bitter irony they point out 
that as the international community mobilizes around the MDG of reducing infant 
and child mortality, most of the 200,000 annual deaths associated with the impacts 
of climate change occur in children. After a broad overview of major direct and 
indirect pathways through which global environmental change affects health, they 
point out the unequal distribution of hazards and benefits: ‘those most at risk are 
often least responsible for the change’. Although they conclude on an optimistic 
note with a discussion of the win-win character of many measures to reduce 
greenhouse gas emissions, one wonders whether their optimism is warranted 
given recent history of intransigence on climate change. The basic analytical point 
is th t global environmental policy (and national policy with global environmental 
consequences), like trade policy, is relentlessly interest-driven in a world where 
the distribution of resources and the consequent ability to influence policy is vastly 
unequal.
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Trade policy is, in fact, the subject of the next two chapters. K.S. Mohindra, 
Raphael Lencucha and Ronald Labonté begin Chapter 6 with a short analytical 
overview of the mechanisms by which trade liberalization, a key element of 
globalization, influences health (for a complementary treatment see Blouin, 
Chopra and van der Hoeven 2009) by way of its effects on individual livelihoods 
and national opportunities for economic development. They continue with a 
more detailed investigation of how the emerging regime of WTO treaties and 
proliferating bilateral and regional trade agreements is affecting the prevalence of 
NCDs by way of food, tobacco and alcohol. The fact that ‘[w]hile consumption of 
these products is often viewed as a lifestyle choice, with public health interventions 
often targeting individuals, it is at least as much a reflection of corporate production 
and marketing strategies, government regulation (or lack thereof), and global trade 
and trade treaty disputes’ is not nearly well enough appreciated. Within national 
policy processes, the individualistic bias of public health discourse and practice 
identified by Glasgow almost certainly comes into play as well. Despite the qualified 
initial success of the Framework Convention on Tobacco Control (FCTC), briefly 
summarized in the chapter, the prospects for an effective framework convention 
on obesity control, as advocated in a 2011 Lancet editorial (The Lancet 2011), cannot 
be considered bright, and indeed the editorial’s reference to ‘the current tsunami of 
risk factors’ suggests a partial mis-specification of the problem.9
Natalia Ovtcharenko and colleagues provide a summary of controversies in the 
area of global health politics where corporate influence is probably most familiar 
and pernicious: the conflict between patents and access to essential medicines. 
The process that resulted in worldwide harmonization of intellectual property 
protection under the Trade-Related Aspects of Intellectual Property (TRIPS) 
agreement has been described as one in which ‘[i]n effect, twelve corporations 
made public law for the world’ (Sell 2003, 96). The subsequent political economy of 
intellectual property rights and access to medicine is somewhat more complicated, 
as some middle-income countries begin to develop pharmaceutical industries with 
the capacity to move beyond generic production (Shadlen 2007). The authors offer 
an overview of TRIPS and post-TRIPS efforts to expand flexibilities to enable LMICs 
to address major threats to population health. Especially interesting in terms of 
what it shows about the hard politics of global health is their account of efforts 
to offset these flexibilities with ‘TRIPs-plus’ provisions in bilateral and regional 
9  A cautionary note sounded in the introduction to a special issue of the journal Global 
Heart that app ared at the time of the summit is worth quoting at length: ‘The challenges 
[of NCDs] are much farther upstream and multisectoral than other health challenges; what 
presents as a health issue has its origins in a variety of determinants, and the solutions 
must incorporate agriculture, the food and beverage industry, and the built environment 
among others’ (Smith and Ralston 2011). A similar note was sounded in the European Journal 
of Cancer, emphasizing ‘the human ecology of cancer control’ as ‘a hugely challenging 
area for cancer public policy and one that is frequently neglected, in part because of its 
intrinsic challenge but more so because it forces a dialogue about political ideology and the 
prioritization of expenditure and efforts in cancer control’ (Sullivan and Purushotham 2011, 
2377).
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agreements (see also Roffe, Von Braun and Vivas-Eugui 2008; Shaffer and Brenner 
2009). They conclude on a positive note, with an account of initiatives including 
patent pooling and the Health Impact Fund that aim to improve access to medicines 
within the constraints of the current intellectual property regime, correctly noting 
that the effectiveness of such initiatives cannot yet be assessed.
Health issues are most readily accommodated in foreign policy agendas 
when they are framed in terms of national security (Labonté and Gagnon 
2010). In Chapter 8, Colleen O’Manique provides a brief history of the post-war 
‘securitization’ of global health, noting the tensions between national security as 
conventionally defined and the ‘human security’ paradigm that emerged in the 
1990s. She identifies the limits of even this apparently kinder, gentler perspective 
on security in a world influenced by ‘the broader neoliberal project of the past three 
decades’. These limits are illustrated by the recent history of policy responses to 
HIV and influenza (O’Manique’s description of the political economy of domestic 
responses to the threat of epidemic influenza in southeast Asia is chilling), and 
generically by the selective focus of the health and s curity agenda, which ignores 
the health of those too marginal, economically or geopolitically, to matter much 
in a larger frame of reference. (This is my formulation, not O’Manique’s.) Despite 
the language of interconnectedness and shared vulnerability, as in the case of the 
effects of environmental change described by Bennett and McMichael, not all of 
‘us’ are similarly vulnerable. Against the background of an emerging discourse on 
global health governance (see Chapter 11), O’Manique concludes that: ‘Properly 
framed, a human security perspective asks the basic questions: Governance for 
whom? Who lives, and who dies? And who decides?’
This question is taken up with special urgency in the following chapter by 
Rosalind Petchesky, who blends anthropology and political economy using the 
Foucauldian concept of biopolitics with specific reference to health in Haiti: the 
poorest country in the western hemisphere, most recently in the headlines following 
the earthquake of 2010. Petchesky argues that the savage privation experienced 
by Haitians, and the consequent threats to their health, must be understood with 
reference to a long history of colonial exploitation and Haitian resistance. To this 
she adds both a gender dimension, arguing that issues of sexuality have always 
represented at least a subtext in the history of the country’s exploitation, and a 
devastating critique of contemporary ‘aid’ efforts before and after the earthquake. 
In addition to foregrounding the connection between militarization and 
sexualization, Petchesky’s work reminds all those working in the field of global 
health that the United States and US-based economic interests have a long history 
of actively destroying opportunities to lead a healthy life for those standing in their 
way, or just asking the kinds of questions that recur throughout this book. The 
inexcusable toll of domestic morbidity and mortality following the US invasion 
of Iraq (Burnham 2006), and its close connection to the attempt at forced neo-
liber lization of the Iraqi economy (Schwartz 2007), is anything but the historical 
anomaly as which it is regarded by many of our students and younger colleagues.
Françoise Barten, K.S. Mohindra and I end the section on issues and challenges 
by taking up the question of ‘governance for whom?’ in a metropolitan frame of 
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reference, asking how global economic processes affect social determinants of 
health at a time of rapid urbanization (in those regions of the world not already 
highly urbanized), increasing economic inequality, and intensified conflicts over 
metropolitan space and resources between those connected to the global economy 
on radically different terms. Urban health researchers or epidemiologists studying 
place and health seldom consider these macro-scale processes, yet their importance 
is demonstrated by a poignant example drawn from the experience of one of the 
authors who now works with the government of El Salvador to redesign health and 
social provision on equitable, rights-based lines.
Responses
Such efforts, mainly on a national or international scale, are the focus of the last set 
of chapters. Most authors in this section on policy responses write from experience 
not only as researchers but also as high-level global health politics protagonists. 
Ilona Kickbusch held numerous senior positions in WHO’s European regional 
office and subsequently in Geneva. Rick Rowden worked for many years with the 
development policy civil society organization (CSO) ActionAid, specializing in 
critiques of the International Monetary Fund (IMF)’s approach to development. 
Sir Michael Marmot, perhaps best known as the leader of the two ground-breaking 
Whitehall studies of the health of British public servants, subsequently chaired the 
WHO Commission on Social Determinants of Health; his co-authors, Ruth Bell and 
Sharon Friel, were members of the small secretariat that worked with Marmot on 
drafting the Commission’s final report. Audrey Chapman, who directed the Science 
and Human Rights Program of the American Association for the Advancement of 
Science for 15 years, also participated in drafting the UN Committee on Economic, 
Social and Cultural Rights’ General Comments (key interpretive documents) on 
both the right to health (General Comment 14) and the right to water (General 
Comment 15).
Hein and Kickbusch provide a succinct overview of today’s complex landscape 
of global health politics, including a fourfold increase in the value of development 
assistance for health since 1990; the rise of new categories of institutions such as 
the Global Fund, trans-national CSOs and networks such as Countdown 2015 
that link CSOs ith UN agencies and other institutions; and the emergence of 
new players in old categories. The Bill & Melinda Gates Foundation is the most 
obvious member of the latter group; as noted earlier there is nothing new about 
influential foundations based on one private fortune. One of the more interesting 
manifestations of this new organizational complexity was establishment of the H8 
or He lth 8 in 2007 in an effort to accelerate progress toward the health-related 
MDGs; it comprises senior officials of four UN agencies including WHO; the World 
Bank; the Global Fund; Global Alliance for Vaccines and Immunization (GAVI); 
and the Gates Foundation. Among the authors’ observations, the fact that ‘health 
is one of the largest industries worldwide’ perhaps deserves special attention; this 
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point is likely to be more familiar to researchers who work on domestic health 
policy issues than to those whose focus is primarily international. On a brighter 
note, they suggest that the emerging organizational complexity may represent 
the emergence of new understandings of global democracy, meaning ‘more than 
an equal representation of governments in international institutions’, and global 
citizenship.
Rick Rowden argues that advocacy in support of global health must expand its 
frame of reference to include a critique of current Washington consensus models 
of development policy, including a reconsideration of the value of interventionist 
(neoclassical economists would say protectionist) industrial policies, of a kind 
today’s high-income countries routinely adopted at earlier stages of their journey 
to prosperity. He is especially critical of the equation of p verty reduction with 
development, and of the IMF’s insistence on low inflation and other forms of 
macroeconomic orthodoxy, regardless of their well-established human costs. This 
is not a new critique; as early as 1987 a landmark UNICEF report documented the 
destructive costs of ‘structural adjustment’ policies promoted by the IMF as the 
price of debt restructuring, with specific reference to the health and well-being 
of children (Cornia, Jolly and Stewart, eds 1987). What is new, and imperative, 
is Rowden’s insistence that those whose adv cacy efforts have heretofore been 
focused on the health sector, as it is now described, broaden their efforts to situate 
health in the context of alternative trajectories for economic development – with 
a special focus on how policies of countries like the United States and of the 
international financial institutions influ nce those trajectories and the distribution 
of the benefits of growth.
A similar message, although stated in different terms, is conveyed by Bell 
and colleagues in their descripti n of the genesis of the CSDH and responses 
to its findings. They situate the Commission’s work as, in many respects, a 
return to the 1978 Alma Ata commitment to Health for All in the year 2000, 
which ‘foundered during the 1980s in an era of politically motivated market 
liberalisation’, and summarize the report’s findings with special emphasis on the 
ubiquity of socioeconomic gradients in health and their origins in social processes 
and political choices.10 They describe as an ‘extraordinary synchronicity’ the fact 
that the Commission’s report was released in August 2008, two months before a 
serious global financial crisis demonstrated the perils of unregulated economic 
interconnectedness need for reforming the rules that govern the world economic 
order. The next-to-last section of their chapter is a participants’ account of how the 
Commission’s report was received by governments, notably those of the United 
Kingdom and the European Union, but also those of some LMICs. Even within 
national borders, the ‘whole of government approach’ that the Commission correctly 
identified as essential to integrating social determinants of health into public policy 
is difficult; the difficulties multiply internationally, for reasons of political economy 
(some of which are suggested throughout the Issues and Challenges section of the 
10  Those who have not read the Commission’s full report, readily available on-line, are 
strongly encouraged to do so.
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book) as well as reasons of organizational complexity described in Chapter 11. Bell 
and colleagues were ‘optimistic about the prospects for the initiatives … that are 
driving the social determinants of health agenda forward’; as noted in the Coda, 
events at the World Conference on Social Determinants of Health might have been 
read as dampening that optimism somewhat.
In the final substantive chapter, Chapman points out that a range of human 
rights instruments, many of them binding as a matter of international law on states 
that have ratified them, address access to health care and social determinants 
of health. After an overview of the relevant international legal framework, she 
summarizes current interpretations of the right to health, which encompass far 
more than just access to health care. She then describes the limitations of the 
international human rights framework, including the fact that ‘the narrow and 
sometimes excessively legalistic understanding of the right to health held by many 
in the human rights community does not accord sufficient importance to the role 
of the social determinants of health’ but also the ‘relative powerlessness of human 
rights institutions’ as compared, for instance, with the World Bank and the WTO 
regime. She concludes by citing the value of a human rights approach to health 
as both a normative framework and a source of political mobilization, ‘in a world 
in which there are few countervailing normative and policy approaches to the 
dominant neo-liberal ideology underpinning globalization’. My own view is that 
the importance of this point cannot be overstated, in the context of contemporary 
political discourses in which it is sometimes difficult even to imagine what 
historical sociologist Margaret Somers (2008), after Arendt, has called ‘the right to 
have rights’ independent of the marketplace.
Resources and Institutions: Questions for the Future
Without writing another book, it is possible to identify two general sets of questions 
or challenges for health in a globalizing world, and for social scientists working in 
the area.
The first involves resources, first of all for health systems although as the 
Commission on Social Determinants of Health and social epidemiologists remind 
us they are only part of the picture. One study estimated that USD112 billion to 
USD251 billion more would be needed between 2009 and 2015 simply to ensure 
that health systems in low-income countries were capable of meeting the health-
related MDGs (Taskforce on Innovative International Financing 2009). Additional 
development assistance was identified as a priority, but so, too, was mobilizing 
more financing from domestic sources. Many sub-Saharan African countries 
(which accounted for 33 of the 49 countries in the study just cited) were, as of 2010, 
far from meeting a commitment made in 2001 by member states of the African 
Union to increase public spending on health to 15 per cent of general government 
spending. In fact, a meeting of African Union finance ministers repudiated the 
so-called Abuja Declaration in March 2010, only to see it reaffirmed by heads of 
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government (as before, without any target dates) at the African Union summit 
in July of that year. The protection of health, especially the health of the poor, is 
merely one competitor among many for policy attention and state resource , just 
as it is in wealthier countries, and the politics of resource allocation for health and 
health-related social protection in LMICs remains understudied.
A focus on development assistance should not divert attention from other 
aspects of the world economy that drain resources from health and development 
in LMICs. One of the most important of these is capital flight, in which the wealthy 
and well-connected shift assets out of economies where they are desperately 
needed for investment in health and development in order to improve their 
returns and avoid taxation, regulation or the prospect of devaluation (see generally 
Schrecker forthcoming).  As just one illustration of the importance of capital flight, 
in 2011 academic economist Léonce Ndikumana (a former senior researcher with 
the African Development Bank and the United Nations Economic Commission 
for Africa) and colleague James Boyce published the culmination of many years’ 
research on capital flight from sub-Saharan Africa (Ndikumana and Boyce 2011). 
Their assessment, based on a restrictive definition of capital flight that includes 
only illicit flows, was that between 1970 and 2008 the value of flight capital from 
the region – plus imputed interest, on the assu ption that the money shifted out 
of the region was earning at least a small rate of return in its offshore home – was 
$944 billion, or roughly the value of the region’s entire economic product in 2008. 
Another perspective is provided by the observation that  the annual value of capital 
flight from sub-Saharan Africa between 2000 and 2008 was twice the amount of 
additional aid pledged to the region, albeit not delivered, by the G7 at the Gleneagles 
summit in 2005 (Ndikumana 2010). External debt  remains a debilitating constraint 
on public policy in  many LMICs despite successive debt relief initiatives and has 
long been recognized as a consequence, in part, of the ease with which deregulated 
financial markets facilitate capital flight (Naylor 1987; Schrecker 2009b). The 
problem of resources for health and development, in other words, is very much a 
problem of the unequal distribution of power and opportunities within the world 
system, and the replication of those inequalities within national borders.
Resources are not a problem only for LMICs, of course. The situation of WHO, 
functioning on a frozen core budget and therefore highly dependent on discretionary 
contributions from donors, is a case in point. In an earlier commentary, contributor 
Ilona Kickbusch nd a colleague described that fact that the Gates Foundation 
now spends more each year on health than the amount available for WHO’s core 
operations as ‘a scandal of global health governance’ in which WHO member states 
‘are giving up their major instrument to drive health policy and ensure health 
security’ (Kickbusch and Payne 2004, 10–11). We must recall, however, that the 
instrument was given up voluntarily by national governments with other priorities 
– as Hein and Kickbusch remind us, ‘in a world with numerous centres of power, 
many of which are not committed to improving global health governance’.
